Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment.
Callens
Steven
S
De Schacht
Caroline
C
Huyst
Veerle
V
Colebunders
Robert
R
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced*; D019438:Ritonavir / Q000009:adverse effects; D018119:Stavudine / Q000009:adverse effects; D000068698:Tenofovir
D063065:Organophosphonates; D009943:Organophosphorus Compounds; D000068698:Tenofovir; D018119:Stavudine; D000225:Adenine; D016049:Didanosine; D019438:Ritonavir